9 research outputs found
Mitochondrial Alterations in PINK1 Deficient Cells Are Influenced by Calcineurin-Dependent Dephosphorylation of Dynamin-Related Protein 1
PTEN-induced novel kinase 1 (PINK1) mutations are associated with autosomal recessive parkinsonism. Previous studies have shown that PINK1 influences both mitochondrial function and morphology although it is not clearly established which of these are primary events and which are secondary. Here, we describe a novel mechanism linking mitochondrial dysfunction and alterations in mitochondrial morphology related to PINK1. Cell lines were generated by stably transducing human dopaminergic M17 cells with lentiviral constructs that increased or knocked down PINK1. As in previous studies, PINK1 deficient cells have lower mitochondrial membrane potential and are more sensitive to the toxic effects of mitochondrial complex I inhibitors. We also show that wild-type PINK1, but not recessive mutant or kinase dead versions, protects against rotenone-induced mitochondrial fragmentation whereas PINK1 deficient cells show lower mitochondrial connectivity. Expression of dynamin-related protein 1 (Drp1) exaggerates PINK1 deficiency phenotypes and Drp1 RNAi rescues them. We also show that Drp1 is dephosphorylated in PINK1 deficient cells due to activation of the calcium-dependent phosphatase calcineurin. Accordingly, the calcineurin inhibitor FK506 blocks both Drp1 dephosphorylation and loss of mitochondrial integrity in PINK1 deficient cells but does not fully rescue mitochondrial membrane potential. We propose that alterations in mitochondrial connectivity in this system are secondary to functional effects on mitochondrial membrane potential
Islet B-cell dysfunction and the time course of recovery following chronic overinsulinisation of normal rats
Appropriate insulin therapy may preserve or improve islet B-cell function whereas the effects of overinsulinisation are unclear. Pancreatic islet B-cell function was therefore studied after overinsulinisation of normal rats for 4 weeks (fed blood glucose 2.2-4.5 mmol/l, controls 4.1-7.0 mmol/l). Insulin secretion was assessed by a 3-h hyperglycaemic clamp (10.0 mmol/l) performed 1, 48, and 120 h after insulin withdrawal (n = 6 in each group). When the clamp was performed 1 h after insulin withdrawal, clamp insulin concentration was 1.6 +/- 0.1 micrograms/l, compared to 9.3 +/- 1.0 micrograms/l in control rats. The integrated area under the plasma insulin concentration curve was also significantly decreased (4.8 +/- 0.4 vs 20.3 +/- 2.2 micrograms.l-1.h-1, p less than 0.001), but recovered to 9.4 +/- 1.0 micrograms.l-1.h-1 after 48 h, and to 17.5 +/- 1.4 micrograms.l-1.h-1 after 120 h. Pancreatic insulin contents were decreased at 1 h (6 +/- 1 micrograms/g wet wt) and 48 h (54 +/- 12 micrograms/g wet wt) but not at 120 h (221 +/- 30 micrograms/g wet wt) after withdrawal (controls, 303 +/- 29 micrograms/g wet wt) and there was a strong relationship with pancreatic preproinsulin mRNA and the clamp insulin response. Thus, overinsulinisation with prolonged periods of low blood glucose concentrations impairs islet B-cell function, but is reversible over 5 days